Education
About Us
Working with TipRanks
Follow Us
InspireMD (NSPR)
NASDAQ:NSPR
Total Valuation
InspireMD has a market cap or net worth of $75.06M. The enterprise value is -$2.60M.
Market Cap$75.06M
Enterprise Value-$2.60M
Share Statistics
InspireMD has 30,635,345 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,635,345
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
InspireMD’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -81.25%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)-81.25%
Return on Capital Employed (ROCE)-0.86
Revenue Per Employee82.46K
Profits Per Employee-376.53K
Employee Count85
Asset Turnover0.15
Inventory Turnover2.14
Valuation Ratios
The current PE Ratio of InspireMD is 70.82. InspireMD’s PEG ratio is <0.01.
PE Ratio70.82
PS Ratio0.00
PB Ratio0.42
Price to Fair Value3.06
Price to FCF-0.22
Price to Operating Cash Flow-0.23
PEG Ratio<0.01
Income Statement
In the last 12 months, InspireMD had revenue of 7.01M and earned -32.01M in profits. Earnings per share was -0.76.
Revenue7.01M
Gross Profit1.51M
Operating Income-33.50M
Pretax Income-31.95M
Net Income-32.01M
EBITDA-33.22M
Earnings Per Share (EPS)-0.76
Cash Flow
In the last 12 months, operating cash flow was -25.60M and capital expenditures -1.57M, giving a free cash flow of -27.16M billion.
Operating Cash Flow-25.60M
Free Cash Flow-27.16M
Free Cash Flow per Share-0.89
Dividends & Yields
InspireMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change-8.66%
50-Day Moving Average2.51
200-Day Moving Average2.69
Relative Strength Index (RSI)40.81
Average Volume (3m)49.18K
Important Dates
InspireMD upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 9, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
InspireMD as a current ratio of 5.28, with Debt / Equity ratio of 12.13%
Current Ratio5.28
Quick Ratio4.94
Debt to Market Cap0.02
Net Debt to EBITDA0.49
Interest Coverage Ratio0.00
Taxes
In the past 12 months, InspireMD has paid 59.00K in taxes.
Income Tax59.00K
Effective Tax Rate0.04
Enterprise Valuation
InspireMD EV to EBITDA ratio is -2.80, with an EV/FCF ratio of -4.03.
EV to Sales13.37
EV to EBITDA-2.80
EV to Free Cash Flow-4.03
EV to Operating Cash Flow-4.28
Balance Sheet
InspireMD has $26.09M in cash and marketable securities with $1.64M in debt, giving a net cash position of -$24.45M billion.
Cash & Marketable Securities$26.09M
Total Debt$1.64M
Net Cash-$24.45M
Net Cash Per Share-$0.80
Tangible Book Value Per Share$0.86
Margins
Gross margin is 20.32%, with operating margin of -478.00%, and net profit margin of 22.21%.
Gross Margin20.32%
Operating Margin-478.00%
Pretax Margin22.21%
Net Profit Margin22.21%
EBITDA Margin-478.00%
EBIT Margin-478.00%
Analyst Forecast
The average price target for InspireMD is $4.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.50
Price Target Upside93.97% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast8.49%
EPS Growth Forecast6.09%